Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

        User Fee Reports

User Fee Performance Reports

                        
                ADUFA Performance Reports
          AGDUFA Performance Reports
          BsUFA Performance Reports
          GDUFA Performance Reports
          MDUFA Performance Reports
          PDUFA Performance Reports


                OMUFA Performance Reports Home
          About FDA
          Reports, Manuals, & Forms
          Reports
          User Fee Reports
          User Fee Performance ReportsUser Fee Reports User Fee Performance Reports
  	
        Share
    Post
    Linkedin

    Email
    PrintThe various user fee acts require the HHS Secretary to submit annual performance reports to Congress for each fiscal year during which fees are collected. Annual performance reports document FDA performance in meeting goals agreed to by the HHS Secretary. FDA’s user fee act programs include:

Animal Drug User Fee Act (ADUFA) – Focuses on performance goals intended to improve the predictability and timeliness of the review of new animal drug applications (NADAs), supplemental NADAs, and investigational new animal drug (INAD) submissions.
	Animal Generic Drug User Fee Act (AGDUFA) – Focuses on performance goals intended to improve the predictability and timeliness of the review of abbreviated new animal drug applications (ANADAs), supplemental ANADAs, and generic investigational new animal drug (JINAD) submissions.
	Biosimilar User Fee Act (BsUFA) - Focuses on performance goals that strive to expedite the process for the review of biosimilar biological product submissions, including applications, supplements, notifications, responses, and meeting management.
	Generic Drug User Fee Amendments of 2012 (GDUFA) - Focuses on performance goals to improve the predictability and timeliness to the review of human generic drugs.  FDA has also committed to achieve goals related to hiring and establishing parity between the number and rigor of domestic and foreign inspection of human generic drugs manufacturing facilities.
	Medical Device User Fee and Modernization Act (MDUFMA)/Medical Device User Fee Amendments (MDUFA) - Focuses on performance goals intended to significantly improve the timeliness and predictability of FDA’s review of new medical devices.
	Over-the-Counter Monograph Drug User Fee Act (OMUFA) – Focuses on performance goals aimed at improving the efficiency, timeliness, and predictability of FDA's regulatory activities with respect to OTC monograph drugs.
	Prescription Drug User Fee Act (PDUFA) - Focuses on performance goals that apply to the review of original and resubmitted new prescription drug applications and efficacy and manufacturing supplements.  FDA has also committed to achieve certain procedure and processing goals aimed at facilitating and assuring quality in new drug development.

                                                                                  Content current as of:
      02/22/2022User Fee Performance Reports                
                          

                        ADUFA Performance Reports
          AGDUFA Performance Reports
          BsUFA Performance Reports
          GDUFA Performance Reports
          MDUFA Performance Reports
          PDUFA Performance Reports


                        OMUFA Performance Reports
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop